Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6227 USD | -2.70% | -16.42% | +11.20% |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 60.66M |
---|---|---|---|---|---|
Net income 2021 | -23M | Net income 2022 | -15M | EV / Sales 2021 | - |
Net cash position 2021 | 42.19M | Net cash position 2022 | 17.76M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.01
x | P/E ratio 2022 |
-3.95
x | Employees | 9 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 32.56% |
Latest transcript on Tiziana Life Sciences Ltd
1 day | -2.70% | ||
1 week | -16.42% | ||
Current month | -5.19% | ||
1 month | +43.15% | ||
3 months | +20.82% | ||
6 months | +6.44% | ||
Current year | +11.20% |
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.6227 | -2.70% | 158,472 |
24-05-09 | 0.64 | -4.25% | 137,968 |
24-05-08 | 0.6684 | -1.68% | 56,335 |
24-05-07 | 0.6798 | -3.27% | 64,718 |
24-05-06 | 0.7028 | -5.66% | 164,229 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.20% | 62.46M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- TLSA Stock